Tickeron

Tickeron's Halloween AI Sale 10 Years of AI Innovation. Faster AI. Smarter Trading. Instant Market Intelligence. tickeron.com/trading-investi…

NatWest Group ($NWG) Q3 Earnings Show Steady Profit Growth Despite Higher Impairments Operating pretax profit rose 1.9% year over year to £2.23 billion, narrowly ahead of the £2.20 billion company-compiled consensus. Total income climbed 7.1% to £4.64 billion, while net interest income (NII) of £3.56 billion came in slightly below the £3.61 billion consensus estimate. tickeron.com/blogs/natwest-g…

Imperial Oil ($IMO) Delivers Record Q3 Earnings on Robust Downstream Results Imperial Oil reported record third-quarter net income of C$2.454 billion, or C$5.11 per diluted share, up from C$539 million (C$1.07 per share) a year earlier. Results beat analyst expectations, coming in ahead of the C$4.70 per share consensus compiled by LSEG and the C$4.86 estimate from FactSet. tickeron.com/blogs/imperial-…

FibroBiologics ($FBLG) Q3 2026 Earnings Preview: Tracking Cash and Clinical Momentum FibroBiologics is expected to report results for the third quarter of 2026 (the quarter ended September 30, 2026), with Wall Street consensus calling for a loss of $0.63 per share. As a clinical-stage biotechnology company, FBLG generates no product revenue, so investors will focus on research spending and the company's cash position rather than sales figures. tickeron.com/blogs/fibrobiol…

enVVeno Medical ($NVNO) Q3 2026 Update: Narrower Loss and Steady Cash Runway enVVeno Medical reported a third-quarter 2026 net loss of $4.4 million, or $6.29 per share, compared with a net loss of $4.5 million, or $7.89 per share, in the same period last year. Total operating expenses came in at $4.5 million, down from $4.9 million a year earlier, even as the company prepared to launch its pivotal clinical study. tickeron.com/blogs/envveno-m…

ABVC BioPharma ($ABVC): What Investors Should Watch in the Upcoming Q3 2026 Earnings ABVC BioPharma, Inc. (Nasdaq: ABVC) is expected to report its third-quarter 2026 results in mid-November 2026, covering the three months ended September 30, 2026. Analyst consensus calls for a loss of $0.40 per share on revenue of approximately $0.11 million for the period. tickeron.com/blogs/abvc-biop…

AstraZeneca ($AZN) Reports Q3 Revenue Up 7% and Core EPS Rising 17% Total revenue rose 7% year over year to $16.21 billion, ahead of the roughly $16.0 billion consensus estimate. Core earnings per share (EPS) climbed 17% to $2.79, beating the consensus estimate of about $2.60 per share. tickeron.com/blogs/astrazene…

Tiptree ($TIPT) Shows Steady Q3 Progress After Major Portfolio Changes Tiptree reported third quarter 2026 diluted earnings per share (EPS) of $0.14, up from $0.13 in the prior-year period. Net income from continuing operations swung to a profit of $4.6 million, compared with a net loss of $9.5 million a year earlier. tickeron.com/blogs/tiptree-t…

Oppenheimer Holdin$OPY) Posts Q3 2026 Results: Wealth Management Steady Amid Capital Markets Pressure Oppenheimer Holdings reported third-quarter 2026 revenue of $382.0 million, down 10.0% from $424.4 million in the prior-year period. Net income attributable to the company fell to $5.5 million, or $0.52 per basic share ($0.47 diluted), from $21.7 million, or $2.06 per basic share, a year earlier. tickeron.com/blogs/oppenheim…

Mammoth Energy Services ($TUSK) Reports +95% Revenue Growth in Q3 2026 Mammoth Energy Services (TUSK) reported third quarter 2026 revenue of $21.3 million, up 95% from $10.9 million a year earlier. Net income from continuing operations was $0.3 million, or $0.01 per diluted share, a sharp turnaround from a loss of $12.6 million, or $0.26 per share, in the prior-year quarter. tickeron.com/blogs/mammoth-e…

Verra Mobility ($VRRM) Q3 Earnings: Solid Beat Offset by Commercial Segment Pressure Verra Mobility reported third-quarter 2026 revenue of $258.9 million, a 1.2% decline year over year yet above consensus estimates of roughly Adjusted (non-GAAP) earnings per share reached $0.36, comfortably ahead of the $0.26 consensus, while GAAP diluted EPS was $0.27. tickeron.com/blogs/verra-mob…

Civeo Corporation ($CVEO) Delivers 13% Revenue Growth in Q3 2026 Earnings Civeo Corporation (NYSE: CVEO) reported third-quarter 2026 revenue of $193.1 million, up 13% year over year and well above the consensus estimate of roughly $174.05 million. Net income swung to a profit of $5.2 million, or $0.50 per diluted share, compared with a net loss of $0.5 million, or $0.04 per share, in the prior-year quarter. tickeron.com/blogs/civeo-cor…

Mastech Digital ($MHH) Q3 2026: Data & AI Bookings Rise as Staffing Segment Contracts Mastech Digital reported third quarter 2026 revenue of $41.99 million, down 13.4% year over year, driven primarily by softness in its Talent (IT staffing) segment. Non-GAAP diluted earnings per share (EPS) came in at $0.10, while GAAP diluted EPS was roughly breakeven at $0.00, compared to $0.08 in the prior-year period. tickeron.com/blogs/mastech-d…

Canadian National Railway ($CNI) Delivers +18% EPS Growth in Q3 2026 Canadian National Railway reported third-quarter 2026 adjusted diluted earnings per share (EPS) of C$2.16, up 18% from C$1.83 a year earlier and ahead of the C$2.08 consensus estimate. Total revenue rose 15% year over year to C$4.77 billion, roughly C$120 million above analyst forecasts, led by grain and fertilizer, petroleum and chemicals, and automotive shipments. tickeron.com/blogs/canadian-…

WisdomTree ($WT) Q3 2026 Earnings: Record AUM and Profit Beat Tempered by Revenue Miss WisdomTree reported adjusted (non-GAAP) earnings of $0.32 per share for the third quarter of 2026, beating the consensus estimate of $0.30 by about 6.7%. Operating revenue reached $179.4 million, up 42.8% year over year, but came in slightly below the roughly $181 million analysts had expected. tickeron.com/blogs/wisdomtre…

Newell Brands ($NWL) Delivers +3.7% Net Sales Growth in Q3 2026 Turnaround Update Newell Brands reported third-quarter 2026 net sales of $1.9 billion, up 3.7% year over year, with core sales rising 3.3% for a second consecutive quarter of growth. Normalized diluted earnings per share (EPS) came in at $0.20, matching analyst expectations and reaching the high end of the company's guidance range. tickeron.com/blogs/newell-br…

OmniAb ($OABI) Reports +81.4% Revenue Growth in Q3 2026 and Raises Full-Year Guidance OmniAb reported third quarter 2026 revenue of roughly $4.0 million, an 81.4% year-over-year increase from $2.2 million, exceeding consensus estimates. GAAP net loss per share came in at approximately $0.12, essentially in line with analyst expectations. tickeron.com/blogs/omniab-oa…